Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Purpose The aim of this study was to identify characteristics of hypogammaglobulinemia secondary to glucocorticoid therapy and their value in the differential diagnosis to primary forms of antibody deficiency. Methods We investigated prevalence and character of hypogammaglobulinemia in a cohort of 36 patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) on glucocorticoid therapy in comparison to a gender- and age-matched cohort of hospital controls. We therefore determined serum immunoglobulin levels as well as B- and T cell-subsets in the peripheral blood of all participants. In addition, prior serum immunoglobulin levels and clinical data of the GCA and PMR patients were extracted from the electronic patient data-base. Results 21/36 GCA/PMR patients on glucocorticoid treatment developed antibody deficiency. In 19 patients this included IgG and in 13 patients IgG was the only affected isotype. The reduction of IgG was persistent in nearly 50 % of these patients during the observed period. GCA/PMR patients had reduced circulating naive and transitional B cells (p = 0.0043 and p = 0.0002 respectively) while IgM, IgG and IgA memory B cells were preserved. Amongst T-cell subsets, we found a reduction of CD4 memory T cells (p Conclusion Persistent humoral immunodeficiency occurs in about a quarter of GCA/PMR patients under glucocorticoid therapy. Because most patients have isolated IgG deficiency, preserved IgA production and class-switched memory B cells, by…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Diagnostic Criteria for Primary Immunodeficiencies
Conley, M. E., Notarangelo, L. D., & Etzioni, A. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4799 · Cited by 1,042
The EUROclass trial: defining subgroups in common variable immunodeficiency
Wehr, C., Kivioja, T., Schmitt, C., Ferry, B., Witte, T., Eren, E., Vlkova, M., Hernandez, M., Detkova, D., Bos, P. R., et al. (2008) · Blood · doi:10.1182/blood-2007-06-091744 · Cited by 859
Self-citationClinical picture and treatment of 2212 patients with common variable immunodeficiency
Gathmann, B., Mahlaoui, N., Gérard, L., Oksenhendler, E., Warnatz, K., Schulze, I., Kindle, G., Kuijpers, T. W., van Beem, R. T., Guzman, D., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1077 · Cited by 634
Self-citationThe Effect of In Vivo Hydrocortisone on Subpopulations of Human Lymphocytes
Fauci, A. S., & Dale, D. C. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107544 · Cited by 606
Roberts, D. M., Jones, R. B., Smith, R. M., Alberici, F., Kumaratne, D. S., Burns, S., & Jayne, D. R. W. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.11.009 · Cited by 301
Manson, S. C., Brown, R. E., Cerulli, A., & Vidaurre, C. F. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.01.003 · Cited by 269
Corticosteroid effect on immunoglobulins
Settipane, G. A., Pudupakkam, R. K., & McGowan, J. H. (1978) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(78)90101-x · Cited by 189
Prednisone-induced leukocytosis
Shoenfeld, Y., Gurewich, Y., Gallant, L. A., & PINKHAS, J. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90363-6 · Cited by 161
“A Rose is a Rose is a Rose,” but CVID is Not CVID
Yong, P. F. K., Thaventhiran, J. E. D., & Grimbacher, B. (2011) · Advances in immunology · doi:10.1016/b978-0-12-385991-4.00002-7 · Cited by 160
Disturbed B Cell Homeostasis in Newly Diagnosed Giant Cell Arteritis and Polymyalgia Rheumatica
van der Geest, K. S. M., Abdulahad, W. H., Chalan, P., Rutgers, A., Horst, G., Huitema, M. G., Roffel, M. P., Roozendaal, C., Kluin, P. M., Bos, N. A., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38625 · Cited by 148
Cited by
The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management
Patel, S. Y., Carbone, J., & Jolles, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00033 · Cited by 239
Otani, I. M., Lehman, H. K., Jongco, A. M., Tsao, L. R., Azar, A. E., Tarrant, T. K., Engel, E., Walter, J. E., Truong, T. Q., Khan, D. A., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.01.025 · Cited by 208
Unger, S., Seidl, M., van Schouwenburg, P. A., Rakhmanov, M., Bulashevska, A., Frede, N., Grimbacher, B., Pfeiffer, J., Schrenk, K., Munoz, L. E., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.04.041 · Cited by 146
Self-citationTargeting FcRn for immunomodulation: Benefits, risks, and practical considerations
Peter, H., Ochs, H. D., Cunningham‐Rundles, C., Vinh, D. C., Kiessling, P. C., Greve, B., & Jolles, S. R. A. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.016 · Cited by 145
The broad spectrum of lung diseases in primary antibody deficiencies
Cinetto, F., Scarpa, R., Rattazzi, M., & Agostini, C. (2018) · European Respiratory Review · doi:10.1183/16000617.0019-2018 · Cited by 78
Metadata
- Authors
- Wirsum, C., Glaser, C., Gutenberger, S., Keller, B., Unger, S., Voll, R. E., Vach, W., Ness, T., & Warnatz, K.
- Affiliations
- University of Freiburg (DE)
- University Medical Center Freiburg (DE)
- Corresponding author
- Warnatz, Klaus
- ORCID
- Venue
- Journal of Clinical Immunology
- Published
- 2016-03-15
- Volume
- 36
- Issue
- 4
- Pages
- 406-412
- ISSN
- 0271-9142 (ISSN-L)
- 1573-2592
- OpenAlex
- W2297268963
- Cited by
- 64
- References
- 21
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 12 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 10 · 2017: 4
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- German Federal Ministry of Education and Research (BMBF 01EO1303)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- secondary hypogammaglobulinemia, glucocorticoid therapy, primary antibody deficiency, giant cell arteritis, polymyalgia rheumatica, naive B cells, transitional B cells, memory B cells, regulatory T cells, memory CD4+ T cells, common variable immunodeficiency, differential diagnosis
- MeSH terms
- Agammaglobulinemia, Aged, Aged, 80 and over, Female, Glucocorticoids, Humans, Immunoglobulins, Male, Middle Aged, Polymyalgia Rheumatica, Prednisone, Giant Cell Arteritis, Prevalence, B-Lymphocyte Subsets, T-Lymphocyte Subsets
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency. https://app.cochat.ai/papers/10.1007/s10875-016-0264-7
- The paper
- Wirsum, C., Glaser, C., Gutenberger, S., Keller, B., Unger, S., Voll, R. E., Vach, W., Ness, T., & Warnatz, K. (2016). Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-016-0264-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.